Aloesin inhibits hyperpigmentation induced by UV radiation

Clinical and Experimental Dermatology

Volumn 27, Issue 6, 2002, Pages 513-515

  Choi, S ^b   Park, Y I ^a   Lee, S K ^b   Kim, J E ^b   Chung, M H ^b  

^a Korea University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALOESIN; ARBUTIN; CHROMONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FOREARM; HUMAN; HYPERPIGMENTATION; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

ADULT; ANALYSIS OF VARIANCE; ARBUTIN; CHROMONES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; GLUCOSIDES; HUMANS; HYPERPIGMENTATION; MALE; MELANINS; RADIATION INJURIES; ULTRAVIOLET RAYS;

EID: 0036414688     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2002.01120.x     Document Type: Article

References (10)

1. Jin YH, Lee SJ, Chung MH et al. Aloesin and arbutin inhibit tyrosinase activity in a synergistic manner via a different action mechanism. Arch Pharm Res 1999; 22: 232-6.
2. Reynolds T, Dweck AC. Aloe vera leaf gel: A review update. J Ethnopharmacol 1999; 68: 3-37.
3. Lee KY, Park JH, Chung MH et al. Aloesin up-regulates cyclin E/CDK2 kinase activity via inducing the protein levels of cyclin E, CDK2, and CDC25A in SK-HEP-1 cells. Biochem Mol Biol Int 1997; 41: 285-92.
4. Bleehen SS, Pathak MA, Hori Y, Fitzpatrick TB. Depigmentation of skin with 4-isopropylcatechol, mercaptoamines, and other compounds. J Invest Dermatol 1968; 50: 103-7.
5. Friedmann PS, Gilchrest BA. Ultraviolet radiation directly induces pigment production by cultured human melanocytes. J Cell Physiol 1987; 133: 88-94.
6. Jimbow K, Obata H, Pathak MA, Fitzpatrick TB. Mechanism of depigmentation by hydroquinone. J Invest Dermatol 1974; 62: 436-49.
7. Maeda K, Fukuda M. Arbutin: Mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther 1996; 276: 765-9.
8. Morrison ME, Yagi MJ, Cohen G. In vitro studies of 2,4-dihydroxyphenylalanine, a prodrug targeted against malignant melanoma cells. Proc Natl Acad Sci USA 1985; 82: 2960-4.
9. Yagi A, Kanbara T, Morinobu N. Inhibition of mushroom-tyrosinase by Aloe extract. Planta Med 1987; 53: 515-7.
10. Funayama M, Arakawa H, Yamamoto R et al. Effect of alpha- and beta-arbutin on activity of tyrosinases from mushroom and mouse melanoma. Biosci Biotechnol Biochem 1995; 59: 143-4.